HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Accumulated Depreciation (2014 - 2022)

HUTCHMED (China)'s (HMDCF) quarterly Accumulated Depreciation came in at $36.9 million in Q4 2022, up 12.05% year-over-year from $32.9 million in Q4 2021, and up 12.05% quarter-over-quarter from $32.9 million in Q4 2021.

Analysis

HUTCHMED (China) (HMDCF) Accumulated Depreciation (2014 - 2022) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Accumulated Depreciation for 9 consecutive years, with $36.9 million the latest figure, recorded in Q4 2022.

  • On a quarterly basis, Accumulated Depreciation rose 12.05% year-over-year to $36.9 million in Q4 2022; TTM through Dec 2022 was $36.9 million, a 12.05% increase from a year earlier, with the FY2022 full-year figure at $36.9 million, up 12.05% from the prior year.
  • Accumulated Depreciation was $36.9 million for Q4 2022 at HUTCHMED (China), up from $32.9 million in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $36.9 million in Q4 2022 and troughed at $19.3 million in Q2 2018.
  • A 5-year average of $26.4 million and a median of $24.8 million in 2019 frame the typical range for Accumulated Depreciation.
  • Across the five-year window, Accumulated Depreciation increased 25.18% in 2021 and gained 12.05% in 2022, its largest moves.
  • Over 5 years, Accumulated Depreciation stood at $19.8 million in 2018, then gained by 17.78% to $23.4 million in 2019, then grew by 12.54% to $26.3 million in 2020, then advanced by 25.18% to $32.9 million in 2021, then grew by 12.05% to $36.9 million in 2022.
  • The last three Accumulated Depreciation figures came in at $36.9 million (Q4 2022), $32.9 million (Q4 2021), and $26.3 million (Q4 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 36.86 Mn
Dec 31, 2021 32.90 Mn
Dec 31, 2020 26.28 Mn
Dec 31, 2019 23.35 Mn
Dec 31, 2018 19.83 Mn
Jun 30, 2018 19.33 Mn
Dec 31, 2017 17.49 Mn
Jun 30, 2017 15.91 Mn
Dec 31, 2016 14.40 Mn
Jun 30, 2016 14.03 Mn
Dec 31, 2015 13.34 Mn
Dec 31, 2014 12.50 Mn